Tumour-infiltrating CD8+ T cell frequencies were mostly unaffected, although intratumoural CD8+ T cell frequencies increased between mice treated with single-agent anti-CTLA-4 and mice treated with combination checkpoint blockade (figure 1f). Here, CTLA4 is linked to neoplasm.